Jul
23
Droxidopa Phase II trial for Fibro approved
Pharmaceutical company Chelsea Therapeutics International, Ltd today announced that it has has received approval from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) to begin a Phase II trial of Droxidopa, alone and in combination with carbidopa, for the treatment of Fibromyalgia Syndrome (Fibro).
more